EX-99.1 2 ex_150730.htm EXHIBIT 99.1 ex_150730.htm

Exhibit 99.1

 

 

 

 

Protolabs Reports Second Quarter 2019 Financial Results

 

Record Quarterly Revenue of $115.9 million, an increase of 6% over Q2 2018

 

MAPLE PLAIN, Minn. – July 25, 2019 – Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled, quick-turn, on-demand manufacturer, today announced financial results for the second quarter ended June 30, 2019.

 

Second Quarter 2019 Highlights include:

 

 

Revenue for the second quarter of 2019 was $115.9 million, representing a 5.7 percent increase over revenue of $109.7 million for the second quarter of 2018.

 

The number of unique product developers and engineers served through our web-based customer interface totaled 20,840 in the second quarter of 2019, an increase of 4.7 percent over the second quarter of 2018.

 

Net income for the second quarter of 2019 was $16.2 million, or $0.60 per diluted share.

 

Non-GAAP net income was $19.1 million, or $0.71 per diluted share. See “Non-GAAP Financial Measures” below.

 

“Protolabs continues to be a leader in digital manufacturing and achieved record revenue of $115.9 million in the second quarter,” said Vicki Holt, President and Chief Executive Officer. “We continue to focus on serving our customers by expanding our differentiated offering as we launched a metal 3D printing production offer and custom color matching for injection molding.”

 

Additional Second Quarter 2019 highlights include:

 

 

Gross margin was 52.0 percent of revenue for the second quarter of 2019, compared with 54.0 percent for the second quarter of 2018.

 

GAAP operating margin was 16.9 percent of revenue for the second quarter of 2019, compared to 20.0 percent for the second quarter of 2018.

 

Non-GAAP operating margin was 20.6 percent of revenue for the second quarter of 2019, compared to 23.3 percent for the second quarter of 2018. See “Non-GAAP Financial Measures” below.

  EBITDA was $27.8 million, or 24.0% of revenue, for the second quarter of 2019. 
 

Adjusted EBITDA was $31.0 million, or 26.7% of revenue, for the second quarter of 2019.  See "Non-GAAP Financial Measures" below.

  Cash flow from operations was $36.9 million in the second quarter of 2019.
  Cash and investments balance was $150.7 million at June 30, 2019.
 

The Company repurchased $4.1 million, or 40,669 shares, of common stock during the quarter.

 

Protolabs continued to expand its service offering through two new launches in Q2:

 

o

Custom color matching for injection molding

 

o

Production offer for metal 3D printing

 

“Protolabs grew 5.7% in the quarter despite currency headwinds, softness in automotive and industrial markets, and the challenge of transforming our newly acquired RAPID business to Protolabs’ business model,” said John Way, Chief Financial Officer.  “We continue to focus on delighting our customers, driving sequential improvement in our business, and generating strong cash flows to allow us to continue to invest in future growth.”

 

 

 

 

Non-GAAP Financial Measures

 

The company has included non-GAAP revenue growth that excludes the impact of changes in foreign currency exchange rates (collectively, "non-GAAP revenue growth"). Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the company.

 

The company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense and unrealized (gain) loss on foreign currency (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has included non-GAAP operating margin, adjusted for stock-based compensation expense and amortization expense (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, and disposal of businesses (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP operating margin, non-GAAP revenue growth and Adjusted EBITDA, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the company’s business. Accordingly, the company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

 

Conference Call

 

The company has scheduled a conference call to discuss its second quarter 2019 financial results and third quarter outlook today, July 25, 2019 at 8:30 a.m. ET. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. start time. No participant code is required. A presentation containing information on the company’s second quarter 2019 financial results and third quarter outlook will be available prior to the call. A simultaneous webcast of the call and slide presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/sf4ezs6m. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

 

 

 

 

About Protolabs


Protolabs is the world's fastest digital manufacturing source for rapid prototyping and on-demand production. The technology-enabled company produces custom parts and assemblies in as fast as one day with automated 3D printing, CNC machining, sheet metal fabrication, and injection molding processes. Its digital approach to manufacturing enables accelerated time to market, reduces development and production costs, and minimizes risk throughout the product life cycle. Visit protolabs.com for more information.

 

Forward-Looking Statements

 

Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

 

Source: Proto Labs, Inc.

 

Investor Relations Contact:
Protolabs
Dan Schumacher, 763-479-7240
Director of Investor Relations
daniel.schumacher@protolabs.com

 

or

 

Media Contact:
Protolabs
Sarah Ekenberg, 763-479-7560

Marketing Manager, PR & Media

sarah.ekenberg@protolabs.com

 

 

 

 

Proto Labs, Inc.

Condensed Consolidated Balance Sheets

(In thousands)

 

 

   

June 30,

   

December 31,

 
   

2019

   

2018

 
   

(Unaudited)

         

Assets

               

Current assets

               

Cash and cash equivalents

  $ 100,535     $ 85,046  

Short-term marketable securities

    35,867       46,750  

Accounts receivable, net

    62,548       59,155  

Inventory

    9,688       10,087  

Income taxes receivable

    2,852       5,757  

Prepaid expenses and other current assets

    7,826       8,567  

Total current assets

    219,316       215,362  
                 

Property and equipment, net

    248,816       228,001  

Goodwill

    128,752       128,752  

Other intangible assets, net

    18,116       19,850  

Long-term marketable securities

    14,268       23,579  

Operating lease assets

    12,249       -  

Other long-term assets

    4,010       3,441  

Total assets

  $ 645,527     $ 618,985  
                 

Liabilities and shareholders' equity

               

Current liabilities

               

Accounts payable

  $ 21,230     $ 17,411  

Accrued compensation

    14,068       18,130  

Accrued liabilities and other

    10,422       16,702  

Current operating lease liabilities

    3,296       -  

Income taxes payable

    2,417       491  

Total current liabilities

    51,433       52,734  
                 

Long-term operating lease liabilities

    9,218       -  

Long-term deferred tax liabilities

    21,745       20,162  

Other long-term liabilities

    5,018       4,592  
                 

Shareholders' equity

    558,113       541,497  

Total liabilities and shareholders' equity

  $ 645,527     $ 618,985  

 


 

 

 

 

Proto Labs, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share amounts)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2019

   

2018

   

2019

   

2018

 

Revenue

                               

Injection Molding

  $ 55,457     $ 51,586     $ 110,768     $ 102,929  

CNC Machining

    38,888       37,788       76,760       74,519  

3D Printing

    15,266       13,248       29,746       25,573  

Sheet Metal

    5,472       6,309       10,497       12,550  

Other

    849       721       1,613       1,826  

Total revenue

    115,932       109,652       229,384       217,397  
                                 

Cost of revenue

    55,696       50,439       110,288       100,276  

Gross profit

    60,236       59,213       119,096       117,121  
                                 

Operating expenses

                               

Marketing and sales

    19,285       17,557       37,862       34,129  

Research and development

    8,169       7,032       16,182       13,697  

General and administrative

    13,209       12,640       26,031       25,583  

Total operating expenses

    40,663       37,229       80,075       73,409  

Income from operations

    19,573       21,984       39,021       43,712  

Other income, net

    1,125       808       1,338       986  

Income before income taxes

    20,698       22,792       40,359       44,698  

Provision for income taxes

    4,532       4,478       8,682       8,333  

Net income

  $ 16,166     $ 18,314     $ 31,677     $ 36,365  
                                 

Net income per share:

                               

Basic

  $ 0.60     $ 0.68     $ 1.18     $ 1.35  

Diluted

  $ 0.60     $ 0.67     $ 1.17     $ 1.34  
                                 

Shares used to compute net income per share:

                               

Basic

    26,875,153       26,972,990       26,919,016       26,925,673  

Diluted

    27,041,422       27,274,882       27,113,328       27,232,215  

 


 

 

 

 

Proto Labs, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

   

Six Months Ended

 
   

June 30,

 
   

2019

   

2018

 

Operating activities

               

Net income

  $ 31,677     $ 36,365  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Depreciation and amortization

    14,981       12,749  

Stock-based compensation expense

    6,526       5,034  

Deferred taxes

    1,585       1,620  

Gain on sale of businesses

    -       (671 )

Amortization of held-to-maturity securities

    7       276  

Other

    (279 )     7  

Changes in operating assets and liabilities

    391       3,937  

Net cash provided by operating activities

    54,888       59,317  
                 

Investing activities

               

Purchases of property, equipment and other capital assets

    (34,136 )     (43,194 )

Cash used for acquisitions, net of cash acquired

    -       (90 )

Proceeds from sale of businesses

    -       284  

Purchases of other assets and investments

    (4,000 )     -  

Purchases of marketable securities

    (8,983 )     (17,129 )

Proceeds from maturities of marketable securities

    29,170       29,056  

Net cash used in investing activities

    (17,949 )     (31,073 )
                 

Financing activities

               

Payments on debt

    -       (5,000 )

Proceeds from exercises of stock options and other

    2,243       4,696  

Purchases of shares withheld for tax obligations

    (2,418 )     (1,390 )

Repurchases of common stock

    (21,410 )     -  

Net cash used in financing activities

    (21,585 )     (1,694 )

Effect of exchange rate changes on cash and cash equivalents

    135       (652 )

Net increase in cash and cash equivalents

    15,489       25,898  

Cash and cash equivalents, beginning of period

    85,046       36,707  

Cash and cash equivalents, end of period

  $ 100,535     $ 62,605  

 


 

 

 

 

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Net Income per Share

(In thousands, except share and per share amounts)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2019

   

2018

   

2019

   

2018

 

Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and disposal of businesses

                               

GAAP net income

  $ 16,166     $ 18,314     $ 31,677     $ 36,365  

Add back:

                               

Stock-based compensation expense

    3,486       2,726       6,526       5,034  

Amortization expense

    863       799       1,734       1,563  

Unrealized (gain) loss on foreign currency

    (305 )     93       (58 )     248  

Disposal of businesses

    -       (671 )     -       (671 )

Total adjustments 1

    4,044       2,947       8,202       6,174  

Income tax benefits on adjustments 2

    (1,074 )     (1,318 )     (1,993 )     (3,361 )

Non-GAAP net income

  $ 19,136     $ 19,943     $ 37,886     $ 39,178  
                                 
                                 

Non-GAAP net income per share:

                               

Basic

  $ 0.71     $ 0.74     $ 1.41     $ 1.46  

Diluted

  $ 0.71     $ 0.73     $ 1.40     $ 1.44  
                                 

Shares used to compute non-GAAP net income per share:

                               

Basic

    26,875,153       26,972,990       26,919,016       26,925,673  

Diluted

    27,041,422       27,274,882       27,113,328       27,232,215  

 


 

1 Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and disposal of businesses were included in the following GAAP consolidated statement of operations categories:

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2019

   

2018

   

2019

   

2018

 
                                 

Cost of revenue

  $ 797     $ 363     $ 1,530     $ 650  
                                 

Marketing and sales

    614       443       1,163       820  

Research and development

    503       376       926       690  

General and administrative

    2,435       2,343       4,641       4,437  

Total operating expenses

    3,552       3,162       6,730       5,947  
                                 

Other income, net

    (305 )     (578 )     (58 )     (423 )

Total adjustments

  $ 4,044     $ 2,947     $ 8,202     $ 6,174  

 

2 For the three- and six-month periods ended June 30, 2019 and 2018, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. Our non-GAAP tax rates differ from our GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.

 


 

 

 

 

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Operating Margin

(In thousands)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2019

   

2018

   

2019

   

2018

 

Revenue

  $ 115,932     $ 109,652     $ 229,384     $ 217,397  

Income from operations

    19,573       21,984       39,021       43,712  

GAAP operating margin

    16.9 %     20.0 %     17.0 %     20.1 %

Add back:

                               

Stock-based compensation expense

    3,486       2,726       6,526       5,034  

Amortization expense

    863       799       1,734       1,563  

Total adjustments

    4,349       3,525       8,260       6,597  

Non-GAAP income from operations

  $ 23,922     $ 25,509     $ 47,281     $ 50,309  

Non-GAAP operating margin

    20.6 %     23.3 %     20.6 %     23.1 %

 


 

 

 

 

Proto Labs, Inc.

Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA

(In thousands)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2019

   

2018

   

2019

   

2018

 

GAAP net income

  $ 16,166     $ 18,314     $ 31,677     $ 36,365  

Amortization expense

    863       799       1,734       1,563  

Depreciation expense

    6,678       5,691       13,246       11,186  

Interest income, net

    (465 )     (322 )     (1,046 )     (588 )

Tax expense

    4,532       4,478       8,682       8,333  

EBITDA

    27,774       28,960       54,293       56,859  

Add back:

                               

Stock-based compensation expense

    3,486       2,726       6,526       5,034  

Unrealized (gain) loss on foreign currency

    (305 )     93       (58 )     248  

Total adjustments

    3,181       2,819       6,468       5,282  

Adjusted EBITDA

  $ 30,955     $ 31,779     $ 60,761     $ 62,141  

 


 

 

 

 

Proto Labs, Inc.

Comparison of GAAP to Non-GAAP Revenue Growth

(In thousands)

(Unaudited)

 

 

 

   

Three Months Ended
June 30, 2019

   

Three Months

Ended
June 30, 2018

   

%

   

% Change
Constant

 
   

GAAP

   

Adjustments1

   

Non-GAAP

   

GAAP

   

Change2

   

Currencies3

 

Revenues

                                               

United States

  $ 91,149     $ -     $ 91,149     $ 86,354       5.6 %     5.6 %

Europe

    20,940       1,333       22,273       20,213       3.6 %     10.2 %

Japan

    3,843       33       3,876       3,085       24.6 %     25.6 %

Total Revenue

  $ 115,932     $ 1,366     $ 117,298     $ 109,652       5.7 %     7.0 %

 


 

   

Six Months Ended
June 30, 2019

   

Six Months

Ended
June 30, 2018

   

%

   

% Change
Constant

 
   

GAAP

   

Adjustments1

   

Non-GAAP

   

GAAP

   

Change2

   

Currencies3

 

Revenues

                                               

United States

  $ 178,960     $ -     $ 178,960     $ 170,521       4.9 %     4.9 %

Europe

    42,194       2,967       45,161       40,158       5.1 %     12.5 %

Japan

    8,230       121       8,351       6,718       22.5 %     24.3 %

Total Revenue

  $ 229,384     $ 3,088     $ 232,472     $ 217,397       5.5 %     6.9 %

 

1 Revenue for the three- and six-month periods ended June 30, 2019 has been recalculated using 2018 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.

2 This column presents the percentage change from GAAP revenue for the three- and six-month periods ended June 30, 2018 to GAAP revenue for the three- and six-month periods ended June 30, 2019.

3 This column presents the percentage change from GAAP revenue for the three- and six-month periods ended June 30, 2018 to non-GAAP revenue for the three- and six-month periods ended June 30, 2019 (as recalculated using the foreign currency exchange rates in effect during the three- and six-month periods ended June 30, 2018) in order to provide a constant-currency comparison.

 


 

 

 

 

Proto Labs, Inc.

Product Developer Information

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2019

   

2018

   

2019

   

2018

 

Unique product developers and engineers served

    20,840       19,901       31,550       30,625